Stefan Peters

USPTO Granted Patents = 49 (Patent Applications = 20)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 39 (Patent Applications = 43)

Average Co-Inventor Count = 5.0

ph-index = 10

Forward Citations = 289(Granted Patents)

Location History:

Ingelheim, DE (2003)
Biberach, DE (2006 - 2014)
Mettenberg, DE (2020)
Ingelheim am Rhein, DE (2016 - 2021)
Biberach an der Riss, DE (2014 - 2024)

Company Filing History:

47 out of 1,535

Boehringer Ingelheim International Gmbh

patents

3 out of 85

Vitae Pharmaceuticals, Inc.

patents

1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

49 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421218 - Substituted pyrazine-carboxamide derivatives (2025-09-23),

2. 12391737 - Soluble NPY2 receptor agonists (2025-08-19),

3. 12213970 - Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof (2025-02-04),

4. 12178809 - Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof (2024-12-31),

5. 12054525 - NPY2 receptor agonists (2024-08-06),

6. 10941137 - Difluoromethyl-phenyl triazoles (2021-03-09),

7. 10919859 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof (2021-02-16),

8. 10730850 - Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors (2020-08-04),

9. 10550127 - Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes (2020-02-04),

10. 10538490 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof (2020-01-21),

11. RE47493 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity (2019-07-08),

12. 10336729 - 4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors (2019-07-02),

13. 10253004 - Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof (2019-04-09),

14. 10238633 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2019-03-26),

15. 10125101 - Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof (2018-11-13),

Title: The Innovative Journey of Stefan Peters

Introduction: Stefan Peters, a visionary inventor hailing from Biberach an der Riss, Germany, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Stefan Peters holds several patents in various fields, including renewable energy technologies, medical devices, and automotive advancements. His most recent patent involves a revolutionary method for enhancing energy efficiency in industrial processes.

Career Highlights: Throughout his illustrious career, Stefan Peters has worked tirelessly to push the boundaries of innovation. He has been recognized for his pioneering work in developing sustainable solutions for environmental challenges and improving the quality of life for people around the globe.

Collaborations: Stefan Peters has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines and industries has led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: In conclusion, Stefan Peters stands as a beacon of creativity and ingenuity in the world of inventions. His passion for innovation and commitment to making a positive impact on society continue to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.